Our Products Pipeline

Diversified Pipeline

Our in-house engine is helping to explore the molecular targets and the development of small molecules for the treatment of various indication.

INDICATION

TARGET

Discovery        IND-enabling          Phase 1      Phase 2

BPH (prostate)

5 ALPHA

  • 92% 92%

Diabetics

Undisclosed

  • 15% 15%

HIV/AIDS

Undisclosed

  • 15% 15%

Haemorrhoid

Undisclosed

  • 15% 15%

Fibroids

Undisclosed

  • 15% 15%

Hypertension

Undisclosed

  • 15% 15%